AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Colita, A Belhabri, A Chelghoum, Y Charrin, C Fiere, D Thomas, X
Citation: A. Colita et al., Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases, ANN ONCOL, 12(4), 2001, pp. 451-455

Authors: Thiebaut, A Thomas, X Belhabri, A Anglaret, B Archimbaud, E
Citation: A. Thiebaut et al., Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis, ANN HEMATOL, 79(9), 2000, pp. 501-506

Authors: Michallet, M Thiebaut, A Philip, I Charrin, C Vigouroux, C Thomas, X Bilger, K Belhabri, A Guyotat, D Corront, B Salles, B Dumontet, C Peaud, PY Vilque, JP Devidas, A Fiere, D
Citation: M. Michallet et al., Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha, LEUKEMIA, 14(12), 2000, pp. 2064-2069

Authors: Thomas, X Troncy, J Belhabri, A Thiebaut, A Bouheddou, N Michallet, M Fleurette, J Pivot, C Fiere, D Archimbaud, E
Citation: X. Thomas et al., A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia, PRESSE MED, 29(32), 2000, pp. 1745-1751

Authors: Michallet, M Thomas, X Vernant, JP Kuentz, M Socie, G Esperou-Bourdeau, H Milpied, N Blaise, D Rio, B Reiffers, J Jouet, JP Cahn, JY Bourhis, JH Lioure, B Leporrier, M Sotto, JJ Souillet, G Sutton, L Bordigoni, P Dreyfus, F Tilly, H Gratecos, N Attal, M Leprise, PY Demeocq, F Michel, G Buzyn, A Delmas-Marsalet, B Bernaudin, F Ifrah, N Sadoun, A Guyotat, D Cavazzana-Cavo, M Caillot, D De Revel, T Vannier, JP Baruchel, A Fegueux, N Tanguy, ML Thiebaut, A Belhabri, A Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163

Authors: Michallet, M Thiebaut, A Dreger, P Remes, K Milpied, N Santini, G Hamon, M Bjorkstrand, B Kimby, E Belhabri, A Tanguy, ML Apperley, JF
Citation: M. Michallet et al., Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalfof the EBMT Chronic Leukaemias Working Party (CLWP), BR J HAEM, 108(3), 2000, pp. 595-601

Authors: Michallet, M Tanguy, ML Socie, G Thiebaut, A Belhabri, A Milpied, N Reiffers, J Kuentz, M Cahn, JY Blaise, D Demeocq, F Jouet, JP Michallet, AS Ifrah, N Vilmer, E Molina, L Michel, G Lioure, B Cavazzana-Calvo, M Pico, JL Sadoun, A Guyotat, D Attal, M Cure, H Bordigoni, P Sutton, L Buzyn-Veil, A Tilly, M Leporrier, M Fegueux, N Dreyfus, F Rio, B Lutz, P Vernant, JP
Citation: M. Michallet et al., Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM), BR J HAEM, 108(2), 2000, pp. 400-407

Authors: Thomas, X Teillon, MH Belhabri, A Rimokh, R Fiere, D Magaud, JP Archimbaud, E
Citation: X. Thomas et al., Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission, HEM CELL TH, 41(1), 1999, pp. 19-26

Authors: Belhabri, A Thomas, X Troncy, J Assouline, D Michallet, M Wattel, E Tigaud, JD Blanc, M Fiere, D Archimbaud, E
Citation: A. Belhabri et al., Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study, LEUK LYMPH, 36(1-2), 1999, pp. 45-55

Authors: Archimbaud, E Jehn, U Thomas, X De Cataldo, F Fillet, G Belhabri, A Peaud, PY Martin, C Amadori, S Willemze, R
Citation: E. Archimbaud et al., Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction consolidation therapy, followedby a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia, LEUKEMIA, 13(6), 1999, pp. 843-849

Authors: Michallet, M Perrin, MC Belhabri, A Molina, L Nicolini, F Tigaud, JD Sotto, JJ Guyotat, D Fiere, D Archimbaud, E
Citation: M. Michallet et al., Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 145-150
Risultati: 1-11 |